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A B S T R A C T 
Background: Lung cancer in pregnancy is a rare disease compared to other types of 
cancer. However, special issue should be applied in order to maximize benefit for 
mother without harming the fetus. 
 
Methods: We present a case of 37-year-old, five months pregnant woman who came 
to the hospital with chief complain of shortness of breath. Later on, she was found to 
have a stage IV Non-Small Cell Lung Cancer (NSCLC) with adenocarcinoma subtype. 
 
Result: This may be the first lung cancer in pregnancy reported in Indonesia. Being a 
developing country, several challenges emerged before diagnosing patient of having 
lung cancer. 
 
Conclusion: Careful considerations along with multidisciplinary approach are necessary 
to provide the best care for the patient. 
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INTRODUCTION 
 
Being inferior with low incidence in the beginning of 
the twentieth century, the incidence of lung cancer is 
swiftly increasing (1). In 2012, based on GLOBOCAN 
report, 1.8 million or 12.9% of all new cancer cases were 
lung cancer. Besides, over one million people died at the 
same year, which lead lung cancer to be on the first 
place as the most leading cause of cancer mortality (2). 
Looking deeper into sexes, men were previously more 
prone to have lung cancer than women, but nowadays, 
the incidence of lung cancer in women continues to 
increase (3). On the contrary of its commonness, in 
some subgroup of women, especially in pregnant 
women, the cases of lung cancer are still rare (4). Cancer 
in pregnancy is found in one out of 1.000 pregnant 
women with breast, melanoma, cervical cancer and 
hematological malignancies as the most prevalent (5). In 
terms of lung cancer, based on report by Rivas et al, 
there had been 44 cases of pregnant women published 
until 2012 (6) Furthermore, Boussios et al stated that up 
to 2013, there had been 51 cases of lung cancer 
reported in English literature (7). Due to lack of cases 
reported and challenges that may be encountered 
especially between mother's and fetus' well-being, this 
report aims to give another perspective of diagnosing 
and treating lung cancer in expectant woman, especially 
in developing country. 
 
CASE PRESENTATION 
 
A 37-year-old, five months pregnant, Indonesian 
woman came to the hospital with chief complaint of 
increasing shortness of breath since two weeks before 
admission. Patient is a passive smoker (husband and 
parents are smokers) without history of other illnesses 
including cancer. Four months prior to admission, 
patient had a hemoptysis and was clinically diagnosed 
as tuberculosis. The reasons of being clinically 
diagnosed as tuberculosis were due to hemoptysis, 
young woman, non-smoker and malnutrition status. 
Bacteriology and radiology examination was not 
performed initially because there was no sputum 
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produced and pregnancy status. Patient was then given 
anti-tuberculosis drug for two weeks prior to admission, 
she had shortness of breath, her doctor said that she 
had a fluid in both of her lung and pleurocentesis were 
performed with approximately 1 and 2 liter of fluid 
drawn from her lungs. However, after pleurocentesis, 
patient said that her symptoms returned and brought to 
Dr. Cipto Mangunkusumo Hospital (CMH) for further 
evaluation. During admission, ultrasonography 
confirmed complex pleural effusion, then 
thoracocentesis followed by mini-drain installation were 
performed to drain the fluid. On physical examination, 
patient looked moderately ill, tachycardia 120 beats per 
minute (bpm), respiratory rate 26 times per minute, 
peripheral oxygen saturation 97% on 3 liter per minute 
nasal canulla. Moreover, right hemithorax had a muffled 
breath sound and hepatomegaly was found. On 
laboratory examination, hemoglobin 10.4, hematocrit 
32.2%, leukocyte 11,460/mm3, thrombocyte 
297,000/mm3, erythrocyte sedimentation rate 60; 
Aspartate Aminotransferase (AST) and Alanine 
Aminotransferase (ALT) levels: 33 and 17 mg/dL 
respectively, total/direct/indirect bilirubin: 
0.49/0.15/0.34 mg/dL, Ureum/Creatinine: 17/0.3 
mg/dL. CT-scan was not conducted due to pregnancy. 
 
 
 
Figure 1. Post-bronchoscopy chest x-ray. Right pleural 
effusion, possibly with atelectasis. ETT with tip 4.3 cm above 
carina. No sign of pneumothorax, pneumomediastinum or 
subcutaneous emphysema. 
 
Total stenosis of right superior trunk and partial 
stenosis of intermediate trunk due to compression and 
extralumen mass infiltration were found during 
bronchoscopy examination. Post bronchoscopy chest x-
ray can be seen on figure 1. From cytology examination 
of bronchoalveolar lavage and bronchial brushing 
showed a positive sign of poorly differentiated 
carcinoma. However, cytology from pleural fluid did not 
contain malignant tumor cell (figure 2). Lung biopsy 
showed non-small cell lung cancer (NSCLC) with 
adenocarcinoma subtype but no cancer cell was found 
in pleural biopsy. Due to the suspicion of having a mass 
in the liver, liver biopsy was performed. Liver metastasis 
with differential diagnosis of cholangiocarcinoma was 
found from the biopsy. Bronchial biopsy showed tumor 
cells with adenocarcinoma subtype (figure 3). 
 
 
 
Figure 2. Pleura biopsy showed no malignant cell (Hematoxylin 
Eosin stain, 400X). (A) Connective tissue with acute and 
chronic inflammatory cells; (B) Atypical cells.  
(Image courtesy: Department of Anatomic Pathology, Faculty of 
Medicine Universitas Indonesia-Dr Cipto Mangunkusumo National 
General Hospital) 
 
 
 
Figure 3. Bronchial biopsy. (A) Tumor tissue with solid, 
infiltrative, round-shape, eccentric, hyperchromatic, partly 
vesiculer, distinct nucleus, eosinophilic cytoplasm partly with 
mucinous and signel ring cell appearance; (B) Mitotic tumor 
cells. 
(Image courtesy: Department of anatomic Pathology, Faculty of 
Medicine Universitas Indonesia-Dr Cipto Mangunkusumo National 
General Hospital) 
 
Out of these examinations, lung cancer with liver 
metastasis and bilateral pleural effusion was confirmed 
(stage four lung cancer). Evaluation of fetomaternal 
consultant from Obstetrics and Gynecology Department 
showed 23 weeks pregnancy with normal fetal activity, 
no anatomical malformation, tendency of small fetus, 
no sign of hypoperfusion, funneling and shortening (7 
mm) cervix. 
 
DISCUSSION 
 
This case report may be the first lung cancer during 
pregnancy reported in Indonesia. On 2017 June 17th, 
authors tried to search with keywords "cancer and 
pregnancy and Indonesia" on Pubmed, but none was 
found. Moreover, until mid-year of 2017, there was no 
proper cancer registry which provides cancer-related 
information from residents across Indonesia, thus, there 
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may be an underdiagnosed lung cancer in Indonesian 
pregnant women. To summarize, it can be said that lung 
cancer during pregnancy is a rare or underreported 
case. 
Patient was initially presented with hemoptysis and 
was diagnosed with tuberculosis. Hemoptysis is a 
condition where blood expectorated from respiratory 
tract, either from bronchial or pulmonary vasculature 
(8,9). Various etiology may contribute to the occurrence 
of this condition, starting from pulmonary tuberculosis 
(TB), bronchiectasis and necrotizing pneumonia in less 
developed countries, to lung cancer, pulmonary artery 
aneurysms and arteriovenous malformations in 
developed countries (9). Indonesia itself, being a 
developing country, is not only facing threats from 
infectious diseases, but also increasing number of non-
communicable diseases (10). However, because 
Indonesia has the world’s second largest number of 
tuberculosis new cases in 2015 (11), pulmonary 
tuberculosis should be considered most likely as the 
cause of hemoptysis in this patient. Nevertheless, 
further evaluation indicated that this patient had lung 
cancer, which may cause hemoptysis as well. Being a 
double burden country, careful examination should be 
done in order to exclude either infection or lung cancer 
in patient with hemoptysis. 
Diagnosing lung cancer in pregnancy remains a big 
issue due to its masking symptoms/signs, different 
cancer biology and behavior (affected by hormonal, 
immunosuppressive and environmental condition), rare 
cases, physicians' low level of suspicion, being reluctant 
to perform radiology examination, and late referral for 
invasive diagnostic procedure (7). In term of using 
radiology examination as one of the diagnostic 
modalities, fetal exposure is one of the main reasons 
behind the unwillingness. Based on guideline from The 
American College of Obstetricians and Gynecologists, 
radiation may be lethal to a fetus, but it depends on the 
dose and time of exposure. High-dose of radiation 
(more than 1 Gy) during early embryogenesis may 
damage the process of development. However, the 
radiation doses of diagnostic imaging are not as high as 
1 Gy (12). In research done by Patel et al, based on 
animal studies, studies on survivors of atomic bombings 
in Japan and specific groups who were exposed to 
radiation for medical reasons, the lowest estimated 
threshold dose of radiation which may harm fetal is  
approximately 50 mGy during 0-2 weeks after 
conception. The larger gestational age of a fetus, the 
more possible he/she may survive from higher dose of 
radiation (13). In comparison, the fetal radiation doses 
from chest X-Ray and chest CT scan are approximately 
0.0005-0.01 mGy and 0.01-0.66 mGy (depends on 
gestational age, maternal body habitus and certain 
acquisition parameters) (14). Nevertheless, there are no 
known congenital malformations or mental retardation 
risk in diagnostic imaging-related ionizing radiation in 
the exposed fetus, especially after first trimester (7). 
Thus, we can say that chest X-Ray and CT-scan are 
considered relatively safe to be used as diagnostic 
methods in pregnant women, though careful judgment 
should be done to minimize the unneeded exposure. 
This patient was presented with pleural effusion which 
can be diagnosed using ultrasonography and further 
non-radiation procedure will be able to confirm her 
stage IV NSCLC with adenocarcinoma subtype, so CT-
scan was not needed for diagnosis. However, in order to 
know the therapeutic/intervention response of the 
patient, CT-scan/chest x-ray prior to or post the 
initiation of intervention is still a necessary diagnostic 
modality. 
Most cases of lung cancer during pregnancy was 
presented with advanced stage NSCLC with 
adenocarcinoma type. Nine cases from an international 
collaborative showed that all of the pregnant women 
presented in advanced stages also lead to dismal 
prognosis.7 NSCLC also become the most common 
histological type (80-85%), followed by small cell lung 
cancer (SCLC; 10-15%) and the rest are carcinoid of the 
lungs. Of all lung cancer cases, 90% were related to 
smoking, but in pregnant women, more than 40% cases 
occured without evidence of smoking (4,15). 
Upon establishing the diagnosis of lung cancer, careful 
consideration should be made before administrating 
drug. There are several treatment options for lung 
cancer, starting from surgery as the main treatment, 
chemotherapy, radiotherapy and targeted therapy such 
as tyrosine kinase inhibitors (TKIs). Choosing the best 
treatment option should be based on histopathology 
subtype and stage of the disease (16). In pregnant 
women, despite scarce research done in this specific 
population, ESMO Guidelines Working Group 
recommend to use combination of Carboplatin and 
Paclitaxel only in second and third trimester as the main 
treatment modality in NSCLC. Patient who came in the 
first trimester should be observed until second trimester 
or consider pregnancy termination whenever urgent 
treatment is required; third trimester patient should 
also think about pre-term delivery prior to drug 
administration (5). Chemotherapy may increase the 
potential of congenital malformation and fetal adverse 
effects by 10 to 20% especially if it is administered in the 
first trimester. However, administration after the first 
trimester will have no different risk compared to normal 
population (17). The risk of developing fetal 
malformation also depends on the type of 
chemotherapeutic agent, where antimetabolites and 
alkylating agents have the highest risk, while taxanes 
and platinum derivatives are considered as safe to be 
used in second and third trimester, although long-term 
effect is yet to be proven (4). 
Eventually, before making the decision, 
multidisciplinary team from pulmonologists, intensivists, 
hepatologists, medical oncologists, pathologists, 
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obstetric and gynecologists and radiologists sat together 
to discuss the best treatment option. In addition, 
patient and families were explained about the maternal 
benefit and fetal risks before administrating the 
chemotherapy. Multidisciplinary approach, added by 
families and patient involvement, should be taken into 
account to evaluate potential maternal benefit and fetal 
risks before drug administration (4). 
 
CONCLUSION 
 
This may be the first lung cancer in pregnancy 
reported in Indonesia. Being a developing country, 
emerging of lung cancer during pregnancy remains a big 
issue, with a limitation of data, high incidence of 
infectious disease, which may mask the clinical 
presentation of lung cancer, unwillingness to undergo 
radiology examination and late access to more 
advanced diagnostic procedure may lead to the late 
diagnosis of the disease. Moreover, careful 
consideration should be done before administering the 
drug in order to maximize maternal benefit and lower 
fetal risks. Last but not least, multidisciplinary approach 
is highly recommended to provide the best care for the 
patient. 
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